Quantcast

Latest Morphinans Stories

2014-05-19 08:28:11

RICHMOND, Va., May 19, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) announced today that it has entered into a definitive agreement with AntiOp, Inc. to co-develop a naloxone nasal spray to aid in the reversal of opioid overdose with the option to acquire all rights to the product upon receipt of regulatory and marketing approval. The product has the potential to be the first of its kind to treat overdose from opioid prescription painkillers and heroin - a growing...

2014-05-13 23:04:47

TreatmentHelp, drug and rehabilitation website, identifies five states that have gained notoriety for its rising heroin-related problems. Delray Beach, FL (PRWEB) May 13, 2014 For the last 2 decades, heroin has been slowly yet surely plaguing the United States. Death rates resulting from heroin use have been increasing among all age groups. Heroin has also gained notoriety as being the cause of death among talented celebrities such as Janis Joplin, River Phoenix, Philip Seymour Hoffman,...

2014-05-13 16:29:25

DUBLIN, May 13, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Mallinckrodt Inc.'s Exalgo(®) (Hydromorphone Hydrochloride Extended-release Tablets 8 mg, 12 mg and 16 mg). Actavis intends to begin shipping its product shortly and believes that, under applicable Hatch Waxman rules, it may be entitled to marketing exclusivity....

Researchers Combine Graphene And Painkiller Receptor
2014-05-13 03:09:16

University of Pennsylvania Almost every biological process involves sensing the presence of a certain chemical. Finely tuned over millions of years of evolution, the body’s different receptors are shaped to accept certain target chemicals. When they bind, the receptors tell their host cells to produce nerve impulses, regulate metabolism, defend the body against invaders or myriad other actions depending on the cell, receptor and chemical type. Now, researchers from the University of...

2014-05-13 08:31:21

--Webcast and conference call today at 8:30 a.m. EDT-- WAYNE, Penn., May 13, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported business highlights and financial results for the three months ended March 31, 2014. First quarter highlights include: -- Initiated pivotal bioequivalence studies of Egalet-001; -- Received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Egalet-001, an abuse-deterrent,...

2014-05-09 12:26:10

Announces Effort to Coordinate State and Local Response PITTSBURGH, May 9, 2014 /PRNewswire-USNewswire/ -- Governor Tom Corbett today convened a group of local and state health, law enforcement, legislative and judicial officials along with individuals impacted by addiction to discuss the response to Pennsylvania's growing opioid addiction and overdose situation. Opioids can be found in many prescription drugs as well as illegal drugs such as heroin. Between 2009 and 2013, nearly...

2014-05-08 20:24:26

BUNAVAIL PDUFA date June 7, 2014; Pre-launch activities underway to support an anticipated late Q3 2014 launch RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent achievements and an update on business operations and upcoming...

2014-05-08 12:29:29

RICHMOND, Va., May 8, 2014 /PRNewswire-iReach/ -- Dr. Peter Coleman, the National Medical Director of The Coleman Institute, was voted top addiction medicine specialist in Richmond Magazine's 2014 "Top Doctors" survey. Photo - http://photos.prnewswire.com/prnh/20140508/85672 The Richmond Magazine survey asks local physicians to recommend doctors in 82 categories, ranging from neurology, to pediatrics, and to addiction. Dr. Coleman received the most amount of votes in the Addiction...

2014-05-08 08:31:55

RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2014 Health Care Conference. The presentation is scheduled for Tuesday, May 13, 2014 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time) at Encore at Wynn in Las Vegas. The New Drug Application (NDA) for BUNAVAIL for the treatment of opioid dependence is...

2014-05-07 08:33:35

CUPERTINO, Calif., May 7, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and CEO of DURECT Corporation, will be an industry speaker at the Bay Area Prescription Drug Abuse Summit on May 7, 2014 in San Francisco. The summit is an effort to bring together senior policymakers, medical professionals, educators, local, state and federal law enforcement and the community to seek solutions to this problem and to raise awareness of the...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related